{
    "nct_id": "NCT06088654",
    "official_title": "A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Patients With Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymphoma",
    "inclusion_criteria": "Main Inclusion criteria\n\n* Patients with advanced histologically confirmed, documented CD20+ B-cell non-Hodgkin's lymphoma (NHL) including the following types defined by WHO 2016: Diffuse Large B Cell Lymphoma (DLBCL); high grade; thymic; Follicular Lymphoma (FL); Mantle cell lymphoma (MCL); Marginal zone lymphoma (MZL)\n* Relapsed, progressive and/or refractory disease without established alternative therapy\n* Must have received at least 2 prior systemic therapies including at a minimum anti-CD20 antibody therapy (e.g., rituximab) potentially in combination with chemotherapy and/or relapsed after autologous stem cell rescue.\n* Eastern Cooperative Oncology Group (ECOG) performance status of â‰¤ 2\n* Adequate organ and hematological function\n* Able to provide a fresh biopsy from a safely accessible site (or historical biopsy), per investigator determination.\n\nMain Exclusion Criteria\n\n* Patients with another invasive malignancy in the last 2 years\n* Prior chemotherapy, immunotherapy or other anti-cancer therapy within less than 4 weeks before study drug administration.\n* Autologous stem cell transplant or treatment with CAR-T (Chimeric Antigen Receptor T-Cell) cell therapy within 100 days prior to first dose of study drug\n* Subjects with brain or subdural metastases are not eligible, nor those with history of central nervous system (CNS) lymphoma\n* Current or past history of CNS disease, such as stroke, epilepsy, CNS vasculitis, or neurodegenerative disease.\n* Known history of infection with human immunodeficiency virus (HIV) or hepatitis B or C\n* Major surgery within 4 weeks before the first dose of study drug\n* Comorbidities including diabetes, cardiovascular diseases, immunodeficiencies/autoimmune condition\n* Pregnant / breastfeeding woman\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}